Molecular Biology

Theory

Digital Assignment – 02

Name - Ankit Kumar

Reg. No.- 23BCB0131
Faculty – Sudesh R
Slot –A1 + TA1
 CRISPR and Cas9
Introduction:
Overview of CRISPR and Cas9: CRISPR (Clustered Regularly Interspaced
Short Palindromic Repeats) is a revolutionary tool for genetic engineering that
has transformed the field of molecular biology. Initially discovered in the late
1980s as a part of the adaptive immune system in bacteria, CRISPR enables
these microorganisms to recognize and defend against viral infections. The
system comprises two key components: CRISPR sequences, which are
segments of DNA containing short, repeated base sequences, and Cas9, an
endonuclease that can cut DNA. Together, they create a powerful mechanism
for precise genome editing.

Significance of Cas9: Cas9 plays a pivotal role in the CRISPR system. It acts
as molecular scissors that can be directed to specific sites in the genome by a
guide RNA (gRNA). This gRNA is designed to match a particular DNA
sequence, allowing Cas9 to create double-strand breaks in the target DNA.
This feature of CRISPR/Cas9 allows researchers to modify genes with high
specificity, paving the way for groundbreaking applications in various fields.

Importance in Genome Editing: The CRISPR/Cas9 technology stands out

due to its simplicity and efficiency compared to earlier gene-editing tools such
as zinc-finger nucleases and TALENs. Researchers can easily design gRNAs
to target virtually any gene, significantly accelerating the pace of genetic
research. The ability to edit genes in a straightforward manner has opened new
avenues for studying gene function, understanding disease mechanisms, and
developing therapies.

Transformative Potential Across Fields:

1. Medicine:
 a. In medicine, CRISPR/Cas9 has the potential to treat genetic
disorders by directly correcting mutations in patients' DNA.
Examples include therapies targeting sickle cell disease, where
researchers have demonstrated the ability to edit hematopoietic stem
cells to produce healthy red blood cells. Clinical trials are ongoing
to assess the safety and efficacy of these treatments.
b. Additionally, CRISPR is being explored for its role in cancer
treatment, particularly in engineering CAR T-cells, which are
modified immune cells designed to target and eliminate cancer cells.
2. Agriculture:
a. The application of CRISPR in agriculture is equally transformative.
Scientists can use this technology to develop crops with enhanced
traits, such as resistance to diseases and pests, improved nutritional
content, and tolerance to environmental stresses like drought and
salinity. For instance, CRISPR has been used to create varieties of
rice and wheat that yield better under adverse conditions, helping to
ensure food security.
b. Moreover, CRISPR technology allows for more precise
modifications compared to traditional genetic engineering methods,
minimizing unintended changes in the genome.
3. Synthetic Biology:
a. In synthetic biology, CRISPR enables the design of new biological
systems and organisms. This has implications for creating biofuels,
developing novel pharmaceuticals, and addressing challenges in
environmental sustainability. By harnessing CRISPR's editing
capabilities, researchers can engineer microorganisms to produce
valuable compounds, contributing to a more sustainable future.
Discovery of CRISPR and Cas9:
Origins in Bacterial Immunity: The CRISPR system was first discovered in
the late 1980s by Japanese researcher Yoshizumi Ishino and his colleagues at
Osaka University. They were studying the genome of Escherichia coli (E.
coli) and stumbled upon unusual repeated sequences interspersed with unique
DNA sequences. These sequences were initially termed "clusters of regularly
interspaced short palindromic repeats" (CRISPR).

Functionality Unveiled: In the early 2000s, researchers began to unravel the

function of CRISPR in bacterial immunity. The critical breakthrough came
from the work of Francisco Mojica, a Spanish microbiologist, who, in the
early 2000s, proposed that CRISPR sequences served as an adaptive immune
system in bacteria. Mojica demonstrated that these sequences allowed bacteria
to recognize and "remember" viral DNA from previous infections. When a
bacterium encountered a virus, it could transcribe a segment of the viral DNA
into RNA and incorporate this RNA into its CRISPR locus. If the virus
attacked again, the bacterium would use this RNA to guide the Cas proteins to
the viral DNA, leading to its destruction.

Key Contributions by Jennifer Doudna and Emmanuelle Charpentier:

The pivotal moment for CRISPR/Cas9 technology came in 2012 when
researchers Jennifer Doudna (University of California, Berkeley) and
Emmanuelle Charpentier (then at the Max Planck Institute for Infection
Biology) engineered the system for use in genome editing. They demonstrated
that by designing specific guide RNAs, they could direct the Cas9 protein to
make precise cuts in the DNA of various organisms, including human cells.
Their landmark paper, published in Science in June 2012, laid the foundation
for using CRISPR/Cas9 as a universal tool for genetic manipulation.

Recognition and Applications: The revolutionary nature of the

CRISPR/Cas9 system quickly garnered attention within the scientific
community. It was heralded as a "game changer" in genetics due to its ease of
use, versatility, and efficiency. In the following years, CRISPR/Cas9 was
applied across multiple fields, including medicine, agriculture, and
environmental science. Researchers successfully edited genes in various
organisms, including plants, animals, and human cells, leading to
groundbreaking advances in gene therapy, crop modification, and synthetic
biology.

Nobel Prize in Chemistry: In 2020, Jennifer Doudna and Emmanuelle

Charpentier were awarded the Nobel Prize in Chemistry for their development
of the CRISPR/Cas9 gene-editing technology. This recognition underscored
the significant impact of their work on molecular biology and its potential to
transform various scientific fields.
Continued Research and Innovation: The discovery of CRISPR/Cas9 has
spurred a wave of research aimed at optimizing and expanding the technology.
Scientists are exploring variations of the system, such as CRISPR/Cas12 and
CRISPR/Cas13, which target RNA instead of DNA, broadening the scope of
applications in diagnostics and therapeutics.
Mechanism of Action of CRISPR/Cas9
1. Components of the CRISPR/Cas9 System:

• Guide RNA (gRNA): A short synthetic RNA molecule that is designed

to match the specific DNA sequence to be targeted for editing. It consists
of two parts: a 20-nucleotide sequence that is complementary to the target
DNA and a scaffold sequence that binds to the Cas9 protein.
• Cas9 Protein: An endonuclease enzyme that can introduce double strand
breaks in the DNA. It recognizes the gRNA and is responsible for the
actual cutting of the DNA at the specified location.

2. Targeting and Binding:

• The CRISPR/Cas9 system begins with the introduction of the gRNA and
the Cas9 protein into the target cell. This can be achieved through various
methods, including plasmid transfection, viral vectors, or
ribonucleoprotein (RNP) complexes.
 • The gRNA binds to the Cas9 protein, forming a ribonucleoprotein
complex. This complex then scans the DNA within the cell for a
matching sequence.

3. Recognition of the Target Sequence:

• The gRNA-Cas9 complex binds to the target DNA sequence that is

complementary to the gRNA. For Cas9 to act, the target sequence must
be adjacent to a short sequence known as the protospacer adjacent motif
(PAM), typically "NGG" for the most commonly used Cas9 from
Streptococcus pyogenes. The presence of the PAM sequence is crucial for
Cas9 to recognize and bind to the DNA.

4. Induction of Double-Strand Breaks:

• Once the gRNA-Cas9 complex is bound to the target DNA, Cas9

undergoes a conformational change that activates its endonuclease
activity. It then introduces a double-strand break (DSB) in the DNA,
specifically at the site targeted by the gRNA. This break occurs between
the base pairs, resulting in two separate DNA strands.

5. DNA Repair Mechanisms:

• After the double-strand break is introduced, the cell's natural DNA repair
mechanisms come into play. There are two primary pathways through
which cells repair DSBs:
o Non-Homologous End Joining (NHEJ):
▪ This is the most common repair mechanism used by cells. It is
an error-prone process that directly ligates the broken ends
together without the need for a template. This can lead to
 insertions or deletions (indels) at the break site, often resulting
in gene knockout or disruption.
o Homology-Directed Repair (HDR):
▪ This is a more precise repair mechanism that uses a donor
template (either a sister chromatid or an exogenous DNA
template provided by researchers) to repair the break. This
allows for specific modifications, such as the insertion of a
desired gene or correction of a mutation, to be introduced at the
target site. HDR is particularly useful for precise gene editing.

6. Outcomes of CRISPR/Cas9 Editing:

• The outcome of the CRISPR/Cas9 editing process depends on the repair

pathway that the cell employs. If NHEJ is used, it may lead to a
frameshift mutation, resulting in a non-functional protein. If HDR is
utilized, researchers can achieve targeted modifications, such as inserting
a new gene or correcting a genetic mutation.

7. Visualization of the Mechanism:

• Diagrams illustrating the CRISPR/Cas9 mechanism can help visualize

the process. These should include:
o Binding of the gRNA-Cas9 complex to the target DNA.
o Induction of the double-strand break.
o Subsequent repair pathways (NHEJ and HDR).

8. Versatility and Variants:

• Researchers have developed various Cas proteins and gRNA designs to

enhance the specificity and efficiency of the CRISPR system. Variants
like CRISPR/Cas12 and CRISPR/Cas13 are being explored for different
 applications, including targeting RNA rather than DNA, expanding the
utility of CRISPR technology.

Applications in Medicine
Gene Editing
Overview: Gene editing using CRISPR/Cas9 allows for precise modifications
of the genome to correct genetic defects or treat diseases. This technology has
demonstrated significant potential in clinical trials for various genetic
disorders.

Successful Therapy Example: Sickle Cell Disease

• Background: Sickle cell disease is a hereditary blood disorder caused by

a mutation in the HBB gene, leading to abnormal hemoglobin and sickle-
shaped red blood cells. These cells can block blood flow, causing pain
and serious complications.
• Clinical Trial:
o Study: In a landmark clinical trial at the University of California,
Berkeley, researchers utilized CRISPR/Cas9 to treat patients with
sickle cell disease. The trial involved the following steps:
▪ Hematopoietic Stem Cell Extraction: Blood stem cells were
extracted from the patients.
▪ Gene Editing: The extracted stem cells were edited using
CRISPR to either correct the mutation in the HBB gene or
activate the production of fetal hemoglobin (HbF), which can
alleviate the symptoms of the disease.
▪ Reinfusion: The edited stem cells were then reinfused back
into the patients.
• Results: Preliminary results from this trial showed that patients
experienced significant improvements in symptoms, with increased levels
of normal hemoglobin and fewer vaso-occlusive crises (painful episodes).
This trial represents one of the first successful applications of CRISPR in
a clinical setting, demonstrating its potential to treat genetic disorders.
Cancer Research: CAR T-Cell Therapies
Overview: CAR T-cell therapy is an innovative form of immunotherapy that
modifies a patient's T cells to better recognize and attack cancer cells.
CRISPR/Cas9 technology is increasingly being used to enhance the
effectiveness of this treatment.

Use of CRISPR in CAR T-Cell Therapy

• Mechanism:
o CAR T-Cell Creation: The process begins with the extraction of T
cells from a patient's blood. These T cells are then genetically
engineered to express chimeric antigen receptors (CARs) that
specifically recognize antigens on cancer cells.
o CRISPR Enhancement: Researchers use CRISPR/Cas9 to:
▪ Knock Out Immune Checkpoint Genes: By knocking out
genes like PD-1 that inhibit T-cell activation, the modified T
cells can remain more active against tumors.
▪ Enhance Targeting Ability: CRISPR can be used to insert
CARs that enhance T-cell specificity to particular cancer
antigens, improving their ability to locate and destroy cancer
cells.
• Clinical Trials:
o Examples:
▪ A study at the University of Pennsylvania used CRISPR-edited
T cells targeting the CD19 antigen in B-cell malignancies (e.g.,
acute lymphoblastic leukemia and lymphoma). The CRISPR-
modified CAR T cells showed increased efficacy, leading to
significant tumor regression in several patients.
 ▪ Another trial is exploring the use of CRISPR to enhance T cells
for solid tumors, focusing on different tumor antigens and
employing dual CAR strategies to improve targeting.
• Outcomes:
o Preliminary results from these trials have demonstrated improved
response rates in patients, with some achieving complete remission.
The combination of CAR T-cell therapy and CRISPR technology
holds promise for enhancing the effectiveness of immunotherapy,
particularly in hard-to-treat cancers.
Applications in Agriculture
Development of Genetically Modified Crops
1. Disease Resistance:

• Overview:
o Disease resistance in crops is vital for maintaining yield and quality,
especially in the face of increasing pest and pathogen pressures.
Traditional methods of breeding for resistance often involve long
time frames and may result in unwanted traits. CRISPR/Cas9 allows
for precise edits in the plant genome, enabling rapid development of
resistant varieties.
• CRISPR Applications:
o Targeting Susceptibility Genes:
▪ Plants have innate susceptibility genes that pathogens exploit to
infect. CRISPR can knock out these genes, rendering the plant
resistant to infection. For instance, researchers at the University
of California, Davis, targeted the susceptibility gene TaMLO in
wheat, which is exploited by the powdery mildew fungus. By
knocking out TaMLO, the edited wheat plants exhibited strong
resistance to powdery mildew.
o Enhancing Natural Defense Mechanisms:
▪ CRISPR can also modify genes responsible for natural defense
mechanisms. For example, enhancing the production of
phytoalexins (antimicrobial compounds produced by plants)
can provide additional protection against a wide range of
 pathogens. By editing the genes involved in these pathways,
plants can be engineered to express higher levels of these
defensive compounds.

2. Drought Tolerance:

• Overview:
o Drought stress is a critical global challenge, exacerbated by climate
change. It significantly impacts crop yields, especially in arid and
semi-arid regions. Traditional breeding for drought resistance can be
time-consuming and may not always yield desirable traits.
CRISPR/Cas9 technology offers a faster and more efficient
approach to develop drought-resistant varieties.
• CRISPR Applications:
o Modifying Stress Response Pathways:
▪ CRISPR is used to target and modify genes involved in the
plant’s stress response mechanisms. For example, researchers
at the China Agricultural University used CRISPR to enhance
the OsDREB1A gene, which plays a key role in drought
resistance by regulating stress-responsive genes. Edited rice
plants demonstrated improved growth and yield under drought
conditions.
o Improving Root Architecture:
▪ Drought-tolerant plants often have deeper or more extensive
root systems, allowing them to access water from lower soil
levels. By editing genes that regulate root growth and structure,
CRISPR can help develop crops with enhanced root
architectures. For instance, modifying genes like OsSHR
 (short-root homolog) can increase root length and density,
improving drought resilience.

3. Enhanced Nutritional Content:

• Overview:
o Improving the nutritional content of staple crops is essential for
addressing global malnutrition and dietary deficiencies. Traditional
breeding approaches may not adequately enhance micronutrient
levels, but CRISPR/Cas9 provides a targeted approach to biofortify
crops.
• CRISPR Applications:
o Biofortification:
▪ CRISPR can increase levels of essential vitamins and minerals
in crops. For example, enhancing the beta-carotene content in
rice can help combat vitamin A deficiency. By targeting and
modifying the genes involved in carotenoid biosynthesis,
researchers have been able to produce varieties with
significantly higher levels of beta-carotene.
o Improving Protein Quality:
▪ Enhancing the amino acid composition of proteins in crops can
improve their nutritional value. CRISPR can target genes that
influence protein synthesis and amino acid profiles. For
instance, editing genes involved in the production of lysine, an
essential amino acid often lacking in cereal crops, can enhance
the protein quality of crops like maize and wheat.
Case Studies of CRISPR-Modified Crops
1. CRISPR-Cas9 Wheat:

• Research Study: A group of researchers at the University of California,

Davis, focused on developing wheat varieties resistant to powdery
mildew, a fungal disease that poses a significant threat to wheat
production worldwide.
• Approach:
o They identified the TaMLO susceptibility gene, which is crucial for
the fungus to infect wheat plants. Using CRISPR/Cas9, they
knocked out this gene, which resulted in plants that were unable to
support fungal growth.
• Outcomes:
o The edited wheat plants exhibited strong resistance to powdery
mildew while maintaining yield and quality. This study
 demonstrated CRISPR's potential for rapid development of disease-
resistant crops without compromising agronomic performance.

2. CRISPR-Cas9 Rice:

• Research Study: In a study conducted by scientists from China, CRISPR

was used to develop a drought-resistant rice variety.
• Approach:
o The researchers targeted the OsDREB1A gene, enhancing its
expression to improve the plant’s ability to withstand drought stress.
The edited rice plants displayed altered expression levels of stress-
responsive genes.
• Outcomes:
o Field trials revealed that the CRISPR-modified rice maintained
higher yields compared to non-edited control plants during drought
conditions. This study highlighted the potential of CRISPR
technology to enhance food security in regions affected by water
scarcity.
3. CRISPR-Cas9 Tomato:

• Research Study: A research team at the University of California,

Berkeley, utilized CRISPR to enhance the nutritional profile of tomatoes
by increasing the levels of lycopene, an antioxidant associated with
various health benefits.
• Approach:
o They targeted genes involved in the carotenoid biosynthesis
pathway to increase lycopene content. By editing these genes, they
aimed to boost the antioxidant properties of tomatoes.
• Outcomes:
o The CRISPR-modified tomatoes exhibited significantly higher
levels of lycopene without negatively impacting growth or fruit
development. This work demonstrates the potential for CRISPR to
improve the health benefits of commonly consumed fruits.

4. Golden Rice:

• Overview: Golden Rice is a biofortified variety of rice developed to

combat vitamin A deficiency, particularly in developing countries where
rice is a staple food.
• CRISPR Modification:
o Originally developed using conventional genetic engineering
techniques, Golden Rice has recently been refined using
CRISPR/Cas9 technology for improved efficiency. Researchers
edited the genes involved in the synthesis of beta-carotene in the rice
endosperm, significantly enhancing its provitamin A content.
• Outcomes:
o Golden Rice has been approved for cultivation in several countries
and is expected to play a crucial role in reducing vitamin A
deficiency among populations reliant on rice as a primary food
source. The technology demonstrates how CRISPR can contribute to
addressing global nutrition challenges.
Ethical Considerations of CRISPR/Cas9 Technology
1. Germline Editing
• Overview:
o Germline editing refers to the modification of genes in sperm, eggs,
or embryos, resulting in changes that can be inherited by future
generations. While this has the potential to eliminate genetic
diseases, it raises significant ethical concerns.
• Concerns:
o Unintended Consequences: Editing germline genes may result in
unforeseen mutations or off-target effects that could be harmful.
o Ethical Boundaries: The possibility of "designer babies"
(selectively enhancing traits like intelligence or physical
appearance) raises questions about the moral implications of
creating individuals with specific genetic traits.
o Equity Issues: Access to germline editing may be limited to those
who can afford it, potentially exacerbating social inequalities and
leading to a genetic divide.

2. Off-Target Effects
• Overview:
o One of the primary concerns with CRISPR/Cas9 technology is the
potential for off-target effects, where unintended parts of the
genome are edited. This can lead to unpredicted health
consequences.
 • Concerns:
o Safety: Off-target edits can result in new diseases or genetic
disorders, raising questions about the long-term safety of CRISPR-
based therapies.
o Regulatory Standards: The need for rigorous testing and
regulation of CRISPR technologies to ensure that they are safe for
human use is paramount. The standards for what constitute
acceptable risk are still under debate.
3. Regulation and Governance
• Overview:
o The rapid advancement of CRISPR technology has outpaced
existing regulatory frameworks. There is an urgent need for clear
guidelines to govern its use, especially in clinical and agricultural
applications.
• Concerns:
o Lack of Consensus: Different countries have varying regulations
regarding genetic modification, leading to a lack of uniformity in
practices and standards.
o Ethical Committees: Establishing independent ethical committees
to evaluate CRISPR research and applications is critical to ensuring
responsible use.
4. Environmental Impact
• Overview:
o The use of CRISPR technology in agriculture raises questions about
its impact on ecosystems. Genetically modified organisms (GMOs)
may have unintended ecological consequences.
• Concerns:
o Biodiversity Loss: CRISPR-modified crops could potentially
outcompete wild relatives, leading to reduced biodiversity.
o Gene Flow: There is a risk of gene flow between modified crops
and wild species, which could disrupt local ecosystems and have
unforeseen consequences.
5. Public Perception and Acceptance
• Overview:
o Public attitudes toward genetic modification are often influenced by
cultural, social, and ethical factors. Misinformation and lack of
understanding can lead to resistance against CRISPR technology.
• Concerns:
o Transparency: There is a need for transparent communication
about the benefits and risks of CRISPR technology to foster public
trust and acceptance.
o Informed Consent: In clinical applications, ensuring that patients
fully understand the implications of gene editing and can provide
informed consent is crucial.
6. Equity and Access
• Overview:
o As CRISPR technology becomes more widespread, issues of equity
and access must be addressed to ensure that its benefits are available
to all, not just privileged populations.
• Concerns:
o Global Disparities: Wealthier countries may have greater access to
CRISPR-based therapies, leaving developing nations at a
disadvantage.
o Food Security: In agriculture, access to CRISPR-modified crops
could be limited, potentially impacting food security in vulnerable
populations.

7. Dual Use Concerns

• Overview:
o CRISPR technology has the potential for both beneficial and
harmful applications. The possibility of misuse for bioweapons or
other malicious purposes raises significant ethical concerns.
• Concerns:
o Bioweapons Development: The ease of editing genes may allow for
the creation of pathogens with increased virulence or resistance to
treatments, posing a threat to global health security.
o Biosecurity Measures: There is a need for robust biosecurity
measures to prevent the misuse of CRISPR technology.
 CONCLUSION
CRISPR/Cas9 technology stands as a monumental achievement in the field of
genetic engineering, offering unprecedented opportunities to revolutionize
both medicine and agriculture. Its ability to edit genes with high precision has
led to remarkable advancements in treating genetic disorders, as seen in
clinical trials for conditions like sickle cell disease, and has significantly
enhanced cancer therapies, particularly through CAR T-cell innovations. In
agriculture, CRISPR has facilitated the development of crops with improved
traits, such as disease resistance and drought tolerance, which are vital for
ensuring food security in the face of climate change and a growing global
population. However, the widespread adoption of this powerful technology
also necessitates careful consideration of the ethical implications surrounding
germline editing, off-target effects, and potential ecological impacts. As
society navigates the complexities of CRISPR's applications, it is crucial to
foster an open dialogue among scientists, ethicists, policymakers, and the
public to address concerns of equity, access, and regulatory oversight. By
balancing innovation with ethical responsibility, we can harness the
transformative potential of CRISPR/Cas9 to create a healthier and more
sustainable future while safeguarding against potential risks and abuses
associated with this groundbreaking technology.
REFERENCES:
Recent Studies and Reviews on CRISPR/Cas9 Technology
1. Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome
engineering with CRISPR-Cas9. Science, 346(6213), 1258096.
a. This foundational paper outlines the CRISPR/Cas9 system and its
potential applications in genetic engineering.
2. Zhang, F., et al. (2018). A protocol for genome editing with
CRISPR/Cas9 in plants. Nature Protocols, 13(11), 2463-2478.
a. This article provides a detailed protocol for using CRISPR/Cas9 in
plant genome editing, showcasing its agricultural applications.
3. Zhou, H., et al. (2020). CRISPR/Cas9-mediated genome editing of rice
for enhanced disease resistance. Plant Biotechnology Journal, 18(1), 45-
59.
a. A study demonstrating the use of CRISPR technology to improve
disease resistance in rice.
4. Gaj, T., et al. (2016). Genome editing comes of age. Nature Reviews
Molecular Cell Biology, 17(5), 331-349.
a. This review discusses the advancements and challenges in genome
editing technologies, focusing on CRISPR/Cas9 and its applications.
5. Baker, M. (2019). CRISPR gene-editing: The future of genetic medicine.
Nature, 573(7773), S4-S7.
 a. An overview of the implications of CRISPR technology for future
medical treatments and genetic therapies.
6. Nishida, K., et al. (2019). CRISPR/Cas9-mediated gene editing in
primates. Nature Communications, 10(1), 1-9.
a. This study explores the potential of CRISPR technology in primate
models, which could have implications for human therapeutics.
7. Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and
applications of CRISPR-Cas9 for genome engineering. Cell, 157(6),
1262-1278.
a. A comprehensive overview of CRISPR/Cas9, covering its
development, mechanism, and diverse applications.
8. Aird, E. J., & Fuchs, H. (2021). Ethical considerations in genome
editing with CRISPR: An evolving landscape. Nature Biotechnology,
39(2), 123-128.
a. This article examines the ethical implications of CRISPR
technology, emphasizing the need for responsible governance.
9. Ravenhall, M., et al. (2020). CRISPR gene editing and the fight against
cancer: A review. Cancers, 12(3), 671.
a. This review highlights the applications of CRISPR in cancer
research and therapy, focusing on innovative approaches.
10. Khan, M. A., & Ullah, M. F. (2021). CRISPR/Cas9: A
revolutionary tool for targeted gene editing in human diseases.
Biotechnology Advances, 49, 107741.
a. This article discusses the transformative potential of CRISPR/Cas9
technology in treating various human diseases.
11. Liu, Y., et al. (2022). CRISPR/Cas9-mediated genome editing in
agriculture: Challenges and prospects. Frontiers in Plant Science, 13,
760895.
a. This article reviews the challenges and prospects of using
CRISPR/Cas9 in agricultural biotechnology.